Aquatic Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-711,196
Closed -$17.7M 1709
2025
Q4
$17.7M Buy
+711,196
New +$17.9M 0.5% 44
2025
Q1
Sell
-241,877
Closed -$6.42M 1553
2024
Q4
$6.42M Buy
241,877
+118,677
+96% +$3.22M 0.17% 155
2024
Q3
$3.57M Buy
+123,200
New +$3.59M 0.09% 246
2022
Q3
Sell
-20,900
Closed -$1.1M 1464
2022
Q2
$1.1M Buy
20,900
+20,500
+5,125% +$1.04M 0.36% 70
2022
Q1
$21K Buy
+400
New +$20.8K 0.03% 489

Other funds holding PFE

Aquatic Capital Management's PFE Position: Q1 2026 in Review

Aquatic Capital Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 711,196 shares — an estimated $17.7M sold.

Aquatic Capital Management first reported a position in PFE in Q1 2022 and held it in 5 quarters. The position peaked at $17.7M in Q4 2025. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Aquatic Capital Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 711,196 Pfizer shares in Q1 2026, an estimated $17.7M.
  • Aquatic Capital Management first reported a position in Pfizer in Q1 2022 and held it in 5 quarters.
  • Aquatic Capital Management's Pfizer position peaked at $17.7M in Q4 2025.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.